As of 2026-07-17, the Relative Valuation of Tonix Pharmaceuticals Holding Corp (TNXP) is (203.42) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.85 USD, the upside of Tonix Pharmaceuticals Holding Corp based on Relative Valuation is -1816.6%.
The range of the Relative Valuation is (188.62) - (217.29) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.4x - 25.7x | 22.0x |
| Forward P/E multiples | 20.4x - 23.5x | 22.0x |
| Fair Price | (188.62) - (217.29) | (203.42) |
| Upside | -1691.8% - -1933.7% | -1816.6% |
| Date | P/E |
| 2026-07-15 | -1.26 |
| 2026-07-14 | -1.20 |
| 2026-07-13 | -1.27 |
| 2026-07-10 | -1.36 |
| 2026-07-09 | -1.41 |
| 2026-07-08 | -1.38 |
| 2026-07-07 | -1.37 |
| 2026-07-06 | -1.37 |
| 2026-07-02 | -1.33 |
| 2026-07-01 | -1.35 |
| 2026-06-30 | -1.38 |
| 2026-06-29 | -1.38 |
| 2026-06-26 | -1.43 |
| 2026-06-25 | -1.30 |
| 2026-06-24 | -1.31 |
| 2026-06-23 | -1.29 |
| 2026-06-22 | -1.32 |
| 2026-06-18 | -1.30 |
| 2026-06-17 | -1.32 |
| 2026-06-16 | -1.26 |
| 2026-06-15 | -1.25 |
| 2026-06-12 | -1.23 |
| 2026-06-11 | -1.15 |
| 2026-06-10 | -1.19 |
| 2026-06-09 | -1.24 |
| 2026-06-08 | -1.27 |
| 2026-06-05 | -1.20 |
| 2026-06-04 | -1.28 |
| 2026-06-03 | -1.23 |
| 2026-06-02 | -1.27 |
| 2026-06-01 | -1.33 |
| 2026-05-29 | -1.33 |
| 2026-05-28 | -1.37 |
| 2026-05-27 | -1.31 |
| 2026-05-26 | -1.38 |
| 2026-05-22 | -1.38 |
| 2026-05-21 | -1.51 |
| 2026-05-20 | -1.57 |
| 2026-05-19 | -1.48 |
| 2026-05-18 | -1.54 |
| 2026-05-15 | -1.70 |
| 2026-05-14 | -1.52 |
| 2026-05-13 | -1.50 |
| 2026-05-12 | -1.44 |
| 2026-05-11 | -1.53 |
| 2026-05-08 | -1.52 |
| 2026-05-07 | -1.47 |
| 2026-05-06 | -1.59 |
| 2026-05-05 | -1.46 |
| 2026-05-04 | -1.41 |